Pacira Biosciences, Stock Market Value
| PCRX Stock | USD 21.59 0.70 3.14% |
| Symbol | Pacira |
Pacira BioSciences, Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacira BioSciences,. If investors know Pacira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacira BioSciences, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.48) | Earnings Share (2.24) | Revenue Per Share | Quarterly Revenue Growth 0.011 | Return On Assets |
The market value of Pacira BioSciences, is measured differently than its book value, which is the value of Pacira that is recorded on the company's balance sheet. Investors also form their own opinion of Pacira BioSciences,'s value that differs from its market value or its book value, called intrinsic value, which is Pacira BioSciences,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacira BioSciences,'s market value can be influenced by many factors that don't directly affect Pacira BioSciences,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacira BioSciences,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacira BioSciences, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacira BioSciences,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pacira BioSciences, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pacira BioSciences,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pacira BioSciences,.
| 04/22/2025 |
| 07/21/2025 |
If you would invest 0.00 in Pacira BioSciences, on April 22, 2025 and sell it all today you would earn a total of 0.00 from holding Pacira BioSciences, or generate 0.0% return on investment in Pacira BioSciences, over 90 days. Pacira BioSciences, is related to or competes with Prestige Brand, Evotec SE, Supernus Pharmaceuticals, Collegium Pharmaceutical, PTC Therapeutics, Ironwood Pharmaceuticals, and Ultragenyx. Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practition... More
Pacira BioSciences, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pacira BioSciences,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pacira BioSciences, upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 12.26 | |||
| Value At Risk | (2.88) | |||
| Potential Upside | 4.49 |
Pacira BioSciences, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pacira BioSciences,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pacira BioSciences,'s standard deviation. In reality, there are many statistical measures that can use Pacira BioSciences, historical prices to predict the future Pacira BioSciences,'s volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (1.56) |
Pacira BioSciences, Backtested Returns
Pacira BioSciences, maintains Sharpe Ratio (i.e., Efficiency) of -0.12, which implies the firm had a -0.12 % return per unit of risk over the last 3 months. Pacira BioSciences, exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pacira BioSciences,'s Variance of 4.45, risk adjusted performance of (0.08), and Coefficient Of Variation of (1,064) to confirm the risk estimate we provide. The company holds a Beta of 0.13, which implies not very significant fluctuations relative to the market. As returns on the market increase, Pacira BioSciences,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding Pacira BioSciences, is expected to be smaller as well. At this point, Pacira BioSciences, has a negative expected return of -0.24%. Please make sure to check Pacira BioSciences,'s maximum drawdown, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Pacira BioSciences, performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.1 |
Very weak reverse predictability
Pacira BioSciences, has very weak reverse predictability. Overlapping area represents the amount of predictability between Pacira BioSciences, time series from 22nd of April 2025 to 6th of June 2025 and 6th of June 2025 to 21st of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pacira BioSciences, price movement. The serial correlation of -0.1 indicates that less than 10.0% of current Pacira BioSciences, price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.1 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.98 |
Pacira BioSciences, lagged returns against current returns
Autocorrelation, which is Pacira BioSciences, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pacira BioSciences,'s stock expected returns. We can calculate the autocorrelation of Pacira BioSciences, returns to help us make a trade decision. For example, suppose you find that Pacira BioSciences, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pacira BioSciences, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pacira BioSciences, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pacira BioSciences, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pacira BioSciences, stock over time.
Current vs Lagged Prices |
| Timeline |
Pacira BioSciences, Lagged Returns
When evaluating Pacira BioSciences,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pacira BioSciences, stock have on its future price. Pacira BioSciences, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pacira BioSciences, autocorrelation shows the relationship between Pacira BioSciences, stock current value and its past values and can show if there is a momentum factor associated with investing in Pacira BioSciences,.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pacira Stock Analysis
When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.